finerenonefinerenone-associatedGLP-1 RAsnon-steroidal mineralocorticoid receptor antagonistsSGLT2isUACRinhibitors
…omes and 37% of its improvement in CV outcomes were mediated by finerenone’s effect on decreasing UACR.28 While achieving reduction in UAC…